Abstract:CRISmers, a novel system for screening RNA aptamers, provides an endogenous biological context for the folding of aptamersand proteins, and their interaction. Performance of CRISmers is showcased by identification of a potent neutralizing aptamer against the live severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Omicron variant in vivo. Further, CRISmers is compatible with varying systems, host species, and cellular enrichment methods. RNA aptamers provide useful biological probes and therapeutic agents. New methodologies to screen RNA aptamers will be valuable by complementing the traditional Systematic Evolution of Ligands by Exponential Enrichment (SELEX). Meanwhile, repurposing clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR associated systems (Cas) has expanded their utility far beyond their native nuclease function. Here, CRISmers, a CRISPR/Cas‐based novel screening system for RNA aptamers based on binding to a chosen protein of interest in a cellular context, is presented. Using CRISmers, aptamers are identified specifically targeting the receptor binding domain (RBD) of the spike glycoprotein of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Two aptamer leads enable sensitive detection and potent neutralization of SARS‐CoV‐2 Delta and Omicron variants in vitro. Intranasal administration of one aptamer, further modified with 2'‐fluoro pyrimidines (2'‐F), 2'‐O‐methyl purines (2'‐O), and conjugation with both cholesterol and polyethylene glycol of 40 kDa (PEG40K), achieves effective prophylactic and therapeutic antiviral activity against live Omicron BA.2 variants in vivo. The study concludes by demonstrating the robustness, consistency, and potential broad utility of CRISmers using two newly identified aptamers but switching CRISPR, selection marker, and host species.

Noncanonical crRNAs derived from host transcripts enable multiplexable RNA detection by Cas9

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

Reprogrammed Tracrrnas Enable Repurposing RNAs As Crrnas and Detecting RNAs

Reprogrammed Tracrrnas Enable Repurposing of RNAs As Crrnas and Sequence-Specific RNA Biosensors

Harnessing noncanonical crRNAs to improve functionality of Cas12a orthologs

Progress of CRISPR-based programmable RNA manipulation and detection.

Progress of CRISPR‐based Programmable RNA Manipulation and Detection

A New RNA-Dependent Cas12g Nuclease

Asymmetric CRISPR enabling cascade signal amplification for nucleic acid detection by competitive crRNA

A split crRNA with CRISPR-Cas12a enables highly sensitive, selective, and multiplexed detection of RNA and DNA

Harnessing noncanonical trans -cleavage characteristics of Cas12 and Cas13a to enhance CRISPR-based diagnostics

An Ultrasensitive, One-Pot RNA Detection Method Based on Rationally Engineered Cas9 Nickase-Assisted Isothermal Amplification Reaction.

Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a

Specific Modulation of CRISPR Transcriptional Activators through RNA-Sensing Guide RNAs in Mammalian Cells and Zebrafish Embryos

DNA-guided CRISPR/Cas12 for RNA targeting

Applications of Cas9 as an RNA-programmed RNA-binding protein

Repurposing CRISPR/Cas to Discover SARS‐CoV‐2 Detecting and Neutralizing Aptamers

Sensing endogenous RNA in living human cells using a CRISPR-activated protease

Programmable RNA editing with compact CRISPR–Cas13 systems from uncultivated microbes

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity